Falcon's Invoice Discounting: Your Path to Prosperity
GSPOA World Health Summit Workshop, Usman
1. Global Strategy and Plan of Action for Public Health,
Innovation and Intellectual Property
A Student’s Perspective
Usman A. Mushtaq
Vice president of External Affairs,
International Federation of Medical Students Association
Youth commissioner, The Lancet-University of Oslo and
Harvard Public Health School Commission on Global
Governance for Health
World Health Summit 2012, Berlin
2. Are our innovation & intellectual property
rights doing enough to empower LMICs
to fight such a disease burden, or more
importantly, to merge the growing gap in
stark health inequities?
3. BUT
Rationale for the strategy
• Health inequity: Restricted sharing of
biotechnical and intellectual
advancement in LMICs--> bifurcates into
richer countries with easier access vs.
poorer with limited access.
• Chronic+infectious disease double-
burden: Defeats the inherent purpose of
innovation--> to ameliorate disease
burden and improve health care
accessibility and technical prowess in
LMICs
4. BUT
Rationale for the strategy
•
Ethical & Human Rights Considerations:
•
The Universal Declaration of Human Rights:“Right
to share in scientific advancement and its
benefits..".Denying access to advanced health care and
resources is an ethical violation.
•
Promote innovation in research and development
paradigms unique to LMICs: Which will help in focused
needs-based development and accessible medicines.
5. Implementation
• Over 100 action points over a broad area involving
numerous governing bodies.
• WHO passionately leading the work with progress
of implementation.
• Many initiatives proposed,
• capacity building LMIC on utilizing the TRIPS
flexibilities
• Open source licensing, patent pool, prizes
• Was a step to the Consultative Expert Working
Group on Research and Development
6. Some Challenges
• The strategy so broad that it makes it vague?
• Despite the increased focus on the issue of
access and innovation, progress still remains
slow.
• Many of the solutions lays outside the working
area of WHO and falls under other global
governing bodies
7. Paradoxes of Health and Trade
k on reconcile divergent interests?
• How do member states work on reconcile divergent
interests?
• Do member states prioritize health over trade?
• How can interests around protection of knowledge for
the sake of trade and investment be reconciled with
efforts to produce global public goods?
9. Student-led advoacy
Iconic development
Universities Allied for Essential Medicines
•UAEM Global Health Impact Report Card: Measures
licensure and IP restrictions pertinent to Universities
medical innovations.
•Evaluates on three parameters:
• 1. Access: Are licensed/IP rights protected
biomedical technologies developed by Universities
accessible and affordable to LMICs?
10. Student-led advoacy
Iconic development
• 2. Innovation: How pertinent is the development to
needs of LMICs double disease-burden or poverty
afflictions?
• 3. Curriculum: Does the development do justice to
academia's calling to promote global health
education?
13. Recommendations from the
CEWG on R&D
John-Arne Røttingen, CEWG chair:
“If the price of health products
continues to reflect the full cost of
R&D products, these products will
never be affordable for those that
need them most. We therefore
need to do two things: to delink the
cost of research from the price of
the product, and to develop
mechanisms in addition to
intellectual property rights to
incentivize research investment in
these diseases.”